Combination of Multiple Hemodialysis Modes: Better Treatment Options for Patients Under Maintenance Hemodialysis

Overview

Journal Ther Clin Risk Manag

Publisher Dove Medical Press

Date 2021 Feb 5

PMID 33542633

Citations 1

Authors

Zhi-Yong Zhang

Ming-Xu Li

Hai Yu

Jun Zhao

Feng-Lin Xiao

Fang Xuan

Yi-Xin Zhao

Affiliations

Soon will be listed here.

Abstract

Purpose: Chronic renal failure has become a major public health concern and treatment strategies are urgently needed. We aimed to investigate whether combination of hemodialysis modes was superior to regular hemodialysis for patients under maintenance hemodialysis.

Patients And Methods: A total of 144 patients with end-stage renal failure (ESRF) were enrolled in this single-center retrospective study. Patients received regular hemodialysis (HD) were included in HD group (n=52), patients received regular HD plus hemodiafiltration (HDF) in HD/HDF group (n=47), patients received the combination of regular HD, HDF and hemoperfusion (HP) in HD/HDF/HP group (n=45). After 1-month and 24-months treatment, therapeutic effects were assessed in terms of nutritional status, control of complications, dialysis adequacy, mean arterial pressure (MAP), infection rate and living quality.

Results: When patients received 1-month treatment, there were no statistically significant differences among three groups. After 24-months treatment, patients in HD/HDF and HD/HDF/HP group presented with better dialysis adequacy, lower MAP and infection rate, higher serum albumin, hemoglobin and calcium levels, lower serum phosphorus and intact parathyroid hormone levels, lower incidence of malnutrition and the Hamilton Depression Scale score, higher the Barthel Index score than HD group (<0.05). The levels of calcium, phosphorus and intact parathyroid hormone in HD/HDF/HP group were lower than those in HD/HDF group (<0.05).

Conclusion: Our finding highly indicated that combination of hemodialysis modes was superior to regular HD for patients with ESRF in nutritional status, control of complications, dialysis adequacy, and living quality.

Citing Articles

Pathogenesis and Treatment of Pruritus Associated with Chronic Kidney Disease and Cholestasis.

Kim J, Shim W, Kwak I, Lee D, Park J, Lee S Int J Mol Sci. 2023; 24(2).

PMID: 36675074 PMC: 9864517. DOI: 10.3390/ijms24021559.

References

Song K, Zhao D, Wang Y, Wang Y, Sun X, Miao L . Analysis of Factors Associated with Death in Maintenance Hemodialysis Patients: A Multicenter Study in China. Chin Med J (Engl). 2017; 130(8):885-891. PMC: 5407033. DOI: 10.4103/0366-6999.204103. View

Kovesdy C, Kalantar-Zadeh K . Why is protein-energy wasting associated with mortality in chronic kidney disease?. Semin Nephrol. 2009; 29(1):3-14. PMC: 5500837. DOI: 10.1016/j.semnephrol.2008.10.002. View

Block G, Klassen P, Lazarus J, Ofsthun N, Lowrie E, Chertow G . Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004; 15(8):2208-18. DOI: 10.1097/01.ASN.0000133041.27682.A2. View

Ohtake T, Oka M, Ishioka K, Honda K, Mochida Y, Maesato K . Cardiovascular protective effects of on-line hemodiafiltration: comparison with conventional hemodialysis. Ther Apher Dial. 2012; 16(2):181-8. DOI: 10.1111/j.1744-9987.2011.01042.x. View

Chen L, Wang Z, Zhai S, Zhang H, Lu J, Chen X . Effects of hemoperfusion in the treatment of childhood Henoch-Schönlein purpura nephritis. Int J Artif Organs. 2013; 36(7):489-97. DOI: 10.5301/ijao.5000223. View

Tentori F, Wang M, Bieber B, Karaboyas A, Li Y, Jacobson S . Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Clin J Am Soc Nephrol. 2014; 10(1):98-109. PMC: 4284424. DOI: 10.2215/CJN.12941213. View

James M, Quan H, Tonelli M, Manns B, Faris P, Laupland K . CKD and risk of hospitalization and death with pneumonia. Am J Kidney Dis. 2009; 54(1):24-32. DOI: 10.1053/j.ajkd.2009.04.005. View

Rosselli D, Rueda J, Diaz C . Cost-effectiveness of kidney transplantation compared with chronic dialysis in end-stage renal disease. Saudi J Kidney Dis Transpl. 2015; 26(4):733-8. DOI: 10.4103/1319-2442.160175. View

Hailpern S, Melamed M, Cohen H, Hostetter T . Moderate chronic kidney disease and cognitive function in adults 20 to 59 years of age: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol. 2007; 18(7):2205-13. DOI: 10.1681/ASN.2006101165. View

10.

Davies E, Matza L, Worth G, Feeny D, Kostelec J, Soroka S . Health state utilities associated with major clinical events in the context of secondary hyperparathyroidism and chronic kidney disease requiring dialysis. Health Qual Life Outcomes. 2015; 13:90. PMC: 4487205. DOI: 10.1186/s12955-015-0266-9. View

11.

Nakai S, Iseki K, Tabei K, Kubo K, Masakane I, Fushimi K . Outcomes of hemodiafiltration based on Japanese dialysis patient registry. Am J Kidney Dis. 2001; 38(4 Suppl 1):S212-6. DOI: 10.1053/ajkd.2001.27449. View

12.

Gama-Axelsson T, Heimburger O, Stenvinkel P, Barany P, Lindholm B, Qureshi A . Serum albumin as predictor of nutritional status in patients with ESRD. Clin J Am Soc Nephrol. 2012; 7(9):1446-53. PMC: 3430958. DOI: 10.2215/CJN.10251011. View

13.

James M, Hemmelgarn B, Wiebe N, Pannu N, Manns B, Klarenbach S . Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study. Lancet. 2010; 376(9758):2096-103. DOI: 10.1016/S0140-6736(10)61271-8. View

14.

Donauer J, Schweiger C, Rumberger B, Krumme B, Bohler J . Reduction of hypotensive side effects during online-haemodiafiltration and low temperature haemodialysis. Nephrol Dial Transplant. 2003; 18(8):1616-22. DOI: 10.1093/ndt/gfg206. View

15.

Tattersall J, Canaud B, Heimburger O, Pedrini L, Schneditz D, Van Biesen W . High-flux or low-flux dialysis: a position statement following publication of the Membrane Permeability Outcome study. Nephrol Dial Transplant. 2009; 25(4):1230-2. DOI: 10.1093/ndt/gfp626. View

16.

Nichols W, Nicolini F, Pepine C . Determinants of isolated systolic hypertension in the elderly. J Hypertens Suppl. 1992; 10(6):S73-7. View

17.

Maduell F, Navarro V, Cruz M, Torregrosa E, Garcia D, Simon V . Osteocalcin and myoglobin removal in on-line hemodiafiltration versus low- and high-flux hemodialysis. Am J Kidney Dis. 2002; 40(3):582-9. DOI: 10.1053/ajkd.2002.34918. View

18.

Kacar C, Uzundere O, Kandemir D, Yektas A . Efficacy of HA330 Hemoperfusion Adsorbent in Patients Followed in the Intensive Care Unit for Septic Shock and Acute Kidney Injury and Treated with Continuous Venovenous Hemodiafiltration as Renal Replacement Therapy. Blood Purif. 2020; 49(4):448-456. DOI: 10.1159/000505565. View

19.

Yasuda H, Uchino S, Uji M, Ohnuma T, Namba Y, Katayama S . The lower limit of intensity to control uremia during continuous renal replacement therapy. Crit Care. 2015; 18(5):539. PMC: 4194053. DOI: 10.1186/s13054-014-0539-4. View

20.

DIntini V, Bordoni V, Bolgan I, Bonello M, Brendolan A, Crepaldi C . Monocyte apoptosis in uremia is normalized with continuous blood purification modalities. Blood Purif. 2004; 22(1):9-12. DOI: 10.1159/000074918. View